Kyntra Bio, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · San Francisco, CA
KYNB chart
What traders are saying about $KYNB
Latest postsKyntra Bio, Inc. news
- KYNB Q2 2026 Earnings: Wider-Than-Expected Loss Sends Shares Down 10.6% - Guidance Accuracy Score
https://www.dars.gov.et/ ·
- Kyntra Bio, Inc. Estimates – NASDAQ:KYNB
TradingView ·
- Kyntra Bio stock: Maxim initiates coverage for Kyntra Bio stock at USD 35.00
ad-hoc-news.de ·
- FibroGen Inc (1FG0.DU) stock price, news, quote and history
Yahoo Finance UK ·
- Kyntra Bio Appoints Andrew E. Singer, MBA to its Board of Directors
Yahoo Finance ·
- Kyntra Bio to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Yahoo Finance ·
- Kyntra Bio Continues Balance Sheet Transformation with Material Reduction of Royalty Financing Obligation
Yahoo Finance ·
- Kyntra Bio (KYNB) Q2 2026 Earnings Call Transcript
fool.com ·
- Kyntra Bio Inc (KYNB) (Q2 2026) Earnings Call Highlights: Advancing FG-3246 and Roxadustat with ...
Yahoo Finance ·
- Kyntra Bio (KYNB) Reports Q2 Loss, Lags Revenue Estimates
Yahoo Finance ·
- Kyntra Bio Reports Second Quarter 2026 Financial Results and Provides Business Update
Yahoo Finance ·
- Kamada (KMDA) Q2 Earnings and Revenues Surpass Estimates
Yahoo Finance ·
Kyntra Bio, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $6.4M | $29.6M | $46.8M | $140.7M |
| Net income | $183.5M | -$47.6M | -$284.2M | -$293.7M |
| Diluted EPS | $45.37 | $-11.89 | $-2.92 | $-3.14 |
| Total assets (year end) | $119.6M | $214.5M | $423.5M | $610.1M |
| Cash and equivalents (year end) | $47.9M | $50.5M | $81.6M | $155.7M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Kyntra Bio, Inc.
- Ticker
- KYNB (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Francisco, CA
- Fiscal year end
- December 31
- SEC CIK
- 921299
- Former names
- FIBROGEN INC
Frequently asked questions
What exchange is Kyntra Bio, Inc. listed on?
Kyntra Bio, Inc. trades on the Nasdaq under the ticker symbol KYNB.
What industry is Kyntra Bio, Inc. in?
Kyntra Bio, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Kyntra Bio, Inc. headquartered?
Kyntra Bio, Inc.'s business address on file with the SEC is in San Francisco, CA.
When does Kyntra Bio, Inc.'s fiscal year end?
Kyntra Bio, Inc.'s fiscal year ends on December 31.
How much revenue did Kyntra Bio, Inc. report?
Kyntra Bio, Inc. reported $6.4M in revenue for calendar year 2025, according to its SEC filings.